BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33754606)

  • 1. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
    Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
    Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
    Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
    World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
    Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
    Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
    Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
    Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia.
    Kizilkan Y; Eroglu U; Senel S; Yildizhan M; Balci M; Aykanat IC; Aktas BK; Bulut S; Guzel O; Gokkaya CS; Aslan Y; Ozden C; Tuncel A
    Andrologia; 2022 Feb; 54(1):e14261. PubMed ID: 34590345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the preoperative PSA level for predicting clinically significant incidental transitional zone-prostate cancer before endoscopic enucleation of very large adenoma.
    Misraï V; Pasquie M; Bordier B; Guillotreau J; Gryn A; Palasse J; Bruguière E; Pradere B; Rouprêt M; Zorn KC
    World J Urol; 2020 Apr; 38(4):993-1000. PubMed ID: 31139906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
    Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
    Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
    Magistro G; Keller P; Westhofen T; Schott M; Tamalunas A; Weinhold P; Stief CG
    World J Urol; 2021 May; 39(5):1481-1487. PubMed ID: 32588205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis.
    Cheng BK; Castellani D; Chan IS; Baker A; Gauhar V; Wroclawski ML; Santamaria HT; Tanidir Y; Enikeev D; Chan VW; Ng CF; Herrmann T; Teoh JY
    World J Urol; 2022 Jan; 40(1):87-101. PubMed ID: 34142230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
    Bhuiyan AK; Kibria SA; Subhan SS
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
    Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
    Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Associated Factors of Incidentally Diagnosed Prostatic Carcinoma among Patients Who Had Transurethral Prostatectomy in Tanzania: A Retrospective Study.
    Gunda D; Kido I; Kilonzo S; Nkandala I; Igenge J; Mpondo B
    Ethiop J Health Sci; 2018 Jan; 28(1):11-18. PubMed ID: 29622903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
    Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
    Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer detection in candidates for open prostatectomy.
    Fowler JE; Bigler SA; Kolski JM
    J Urol; 1998 Dec; 160(6 Pt 1):2107-10. PubMed ID: 9817333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.
    He G; Sun C; Shu Y; Wang B; Du C; Chen J; Wen J
    Int J Surg; 2020 Jul; 79():217-221. PubMed ID: 32447004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does mechanical morcellation of large glands compromise incidental prostate cancer detection on specimen analysis? A pathological comparison with open simple prostatectomy.
    Misraï V; Kerever S; Pasquie M; Bordier B; Guillotreau J; Palasse J; Guillotreau V; Rijo E; Vincendeau S; Huet R; Mathieu R; Peyronnet B; Rioux-Leclercq N; Compérat EM
    World J Urol; 2019 Jul; 37(7):1315-1320. PubMed ID: 30350017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
    Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
    Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.